About Prana Biotechnology (NASDAQ:PRAN)
Prana Biotechnology Limited is a development-stage medical biotechnology company. The Company is engaged in the research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's disease, Huntington disease, Parkinson's disease and other neurological disorders. The Company's lead product candidates are PBT2 and PBT434. The Company's lead drug candidate PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. The Company also has advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing. Its other applications for its therapies include certain cancers, age-related macular degeneration, Motor Neuron disease, Creutzfeldt-Jakob disease (the human variant of Mad Cow disease), and a range of orphan neurodegenerative disorders.
Industry, Sector and Symbol
Industry Biotechnology & Medical Research
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$2.37 million
Price / Sales11.98
Price / CashN/A
Book Value$2.01 per share
Price / Book1.59
Return on EquityN/A
Return on AssetsN/A
Prana Biotechnology (NASDAQ:PRAN) Frequently Asked Questions
What is Prana Biotechnology's stock symbol?
Prana Biotechnology trades on the NASDAQ under the ticker symbol "PRAN."
Who are some of Prana Biotechnology's key competitors?
Some companies that are related to Prana Biotechnology include NovaBay Pharmaceuticals (NBY), CytRx (CYTR), Tissue Regenix Group (TRX), OvaScience (OVAS), Vernalis (VER), Aptose Biosciences (APTO), Scancell (SCLP), Immutep (IMMP), AEterna Zentaris (AEZS), Cleveland BioLabs (CBLI), Caladrius Biosciences (CLBS), Oncobiologics (ONS), Genocea Biosciences (GNCA), Repros Therapeutics (RPRX), Bio-Path (BPTH), Can-Fite BioPharma (CANF), Oxford Pharmascience Group (OXP) and Burcon NutraScience (BUR).
Who are Prana Biotechnology's key executives?
Prana Biotechnology's management team includes the folowing people:
- Geoffrey Paul Kempler, Executive Chairman of the Board, Chief Executive Officer
- Kathryn Andrews, Chief Financial Officer
- Dianne Angus, Chief Operating Officer
- David Stamler, Chief Medical Officer and Senior Vice President Clinical Development
- Phillip Hains, Company Secretary
- Ira Shoulson, Non-Executive Director
- Lawrence Gozlan, Non-Executive Independent Director
- Peter Ashley Marks, Non-Executive Independent Director
- Brian Derek Meltzer, Non-Executive Independent Director
- George William Mihaly, Non-Executive Independent Director
How do I buy Prana Biotechnology stock?
Shares of Prana Biotechnology can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Prana Biotechnology's stock price today?
One share of Prana Biotechnology stock can currently be purchased for approximately $3.19.
How big of a company is Prana Biotechnology?
Prana Biotechnology has a market capitalization of $28.39 million and generates $2.37 million in revenue each year. Prana Biotechnology employs 9 workers across the globe.
How can I contact Prana Biotechnology?
Prana Biotechnology's mailing address is LEVEL 2 369 ROYAL PARADE, PARKVILLE C3, 3052. The biotechnology company can be reached via phone at 61-3-9349-4906 or via email at [email protected]
MarketBeat Community Rating for Prana Biotechnology (PRAN)MarketBeat's community ratings are surveys of what our community members think about Prana Biotechnology and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Prana Biotechnology (NASDAQ:PRAN) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for Prana Biotechnology (NASDAQ:PRAN)
No earnings announcements for this company have been tracked by MarketBeat.com
Prana Biotechnology (NASDAQ:PRAN) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Prana Biotechnology (NASDAQ:PRAN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Prana Biotechnology (NASDAQ PRAN)
No insider trades for this company have been tracked by MarketBeat.com
Prana Biotechnology (NASDAQ PRAN) News Headlines
Prana Biotechnology (NASDAQ:PRAN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Prana Biotechnology (NASDAQ:PRAN) Income Statement, Balance Sheet and Cash Flow Statement
Prana Biotechnology (NASDAQ PRAN) Stock Chart for Friday, December, 15, 2017